Products for Research Use Only
RegisterLogin

PDE5-IN-13

CAT: 0804-HY-170435Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-170435Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PDE5-IN-13 (Compound 14b) inhibits phosphodiesterase 5 (PDE5A) with an IC50 of 3 nM. PDE5-IN-13 is a potential candidate for PAH (pulmonary arterial hypertension) research. PDE5-IN-13 has high selectivity for targets over PDE1, PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11. PDE5-IN-13 is orally active[1].
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Smiles
C[C@@H](NC1=CC=CC(C(C2=CC=C(OC)C=C2)=C3C#N)=C1N(CC4=CC=CC=C4)C3=O)C5=CC=CC=N5
Molecular Formula
C31H26N4O2
Molecular Weight
486.56
References & Citations
[1]Zhang B, et.al. Discovery and Optimization of Dihydroquinolin-2 (1H) -ones as Novel Highly Selective and Orally Bioavailable Phosphodiesterase 5 Inhibitors for the Treatment of Pulmonary Arterial Hypertension. J Med Chem. 2024 Dec 26;67 (24) :22134-22144.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
PDE1; PDE10; PDE11; PDE2; PDE3; PDE4; PDE5; PDE6; PDE7; PDE8; PDE9

Related Products

CatalogName
HY-124310PDE5-IN-6c
HY-112704PDE5-IN-2
HY-177298PDE5-IN-15
HY-142059-01PDE5-IN-4
HY-149661PDE5-IN-11
HY-176235PDE5-IN-14
HY-128060PDE5-IN-42
HY-153733PDE5-IN-8
HY-155687PDE5-IN-10
HY-153766-01PDE5-IN-9

Alternative Products

CatalogName
T204706-01PDE5-IN-13
BA8201-5PDE5-IN-4
T28351-01PDE5-IN-42
T79533-01PDE5-IN-10
T12394-01PDE5-IN-2
MBS5774354PDE5-IN-6c
GTR19219490-01PDE5-IN-11
GTR19185471-01PDE5-IN-5
A4712-500PDE5-IN-7
BA8237-10PDE5-IN-9

Popular Products